Neurocrine(NBIX) - 2024 Q3 - Earnings Call Presentation

Advancing Life-Changing Discoveries in Neuroscience Q3 2024 Corporate Presentation October 30, 2024 Nasdaq: NBIX Safe Harbor Statement and Non-GAAP Financial Measures 2 In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/or our product candidates may bring t ...